Healthcare Industry News: ZOLL Medical
News Release - December 28, 2006
ZOLL Receives Marketing Clearance for R Series ''Code-Ready'' Defibrillator in Canada
CHELMSFORD, Mass.--(HSMN NewsFeed)--ZOLL Medical Corporation (NASDAQ: ZOLL ), a manufacturer of resuscitation devices and related software solutions, today announced that it has received a Medical Device License from Health Canada for the ZOLL R Series(TM), which ZOLL believes is the first and only "Code-Ready" defibrillator that can help improve in-hospital resuscitation efforts. This license provides the necessary approval for the marketing and sale of the device in Canada.According to Richard A. Packer, President and Chief Executive Officer of ZOLL, "We define 'Code-Ready' as a device that is simple and always ready to use. The R Series offers a OneStep system that simplifies and speeds up deployment of pacing and defibrillation therapy. It also offers comprehensive, automated readiness checks designed to maximize the readiness of the R Series to help clinicians when they need it most. Its motto is 'Simple, Smart and Ready'. This new device is an important step in continuing ZOLL's growth in North America."
The R Series also offers tools to help clinicians with CPR performance, which is important because more than half of in-hospital codes involve non-shockable rhythms and, in such cases, the only treatment for these rhythms is high-quality CPR with minimal interruptions. The R Series also offers See-Thru CPR(TM) functionality that helps clinicians reduce interruptions. While clinicians are viewing the ECG on a monitor/defibrillator, artifact (i.e., "noise") from manual chest compressions makes it difficult to discern the presence of an organized heart rhythm unless compressions are halted. See-Thru CPR filters out this artifact so that clinicians can view an underlying rhythm without stopping chest compressions.
In addition to See-Thru CPR, the R Series offers a visual aid known as the CPR Index(TM) that allows clinicians to see how well they are performing the rate and depth of chest compressions in real time. This Index, along with optional audible prompts (e.g., "Push Harder" and "Good Compressions"), helps clinicians improve CPR performance by integrating rate and depth into a single indicator on an easy-to-read display. With this feedback, clinicians know how well they are performing compressions and can quickly adjust their compressions to improve blood flow.
Additionally, all CPR performance data and the entire resuscitation record, including the ECG, can be downloaded into ZOLL CodeNet® and reviewed for quality assurance and training purposes. CodeNet is the first system to help document, review, and manage a complete set of data for in-hospital resuscitation events, including both code event data and defibrillator data, on one synchronized timeline.
The R Series also extends testing beyond shock delivery and checks more than 40 measures of readiness, including the presence of the correct cables and electrodes, the type of electrode, and other important electronics. The R Series can also verify the condition and expiration date of the electrode set. All of this testing occurs without disconnecting electrodes or paddles, or requiring additional equipment to test shock delivery. The system provides a printed or electronic log to alert hospital personnel of any concerns in advance of a code.
About ZOLL Medical Corporation
ZOLL Medical Corporation is committed to developing technologies that help advance the practice of resuscitation. With products for pacing, defibrillation, circulation (with ZOLL's See-Thru CPR(TM) and Real CPR Help(TM) technologies), ventilation, and fluid resuscitation, ZOLL provides a comprehensive set of technologies that help clinicians, EMS professionals, and lay rescuers resuscitate sudden cardiac arrest or trauma victims. ZOLL also designs and markets software that automates the documentation and management of both clinical and non-clinical information.
ZOLL markets and sells its products in more than 140 countries. The Company has direct operations, distributor networks, and business partners throughout the U.S., Canada, Latin America, Europe, the Middle East and Africa, Asia, and Australia.
Certain statements contained in this press release regarding matters that are not historical facts are "forward-looking" statements (as defined in the Private Securities Litigation Reform Act of 1995). Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements include, but are not limited to, ZOLL's ability to compete in the resuscitation business; acceptance of its recently launched products; changes in regulations affecting the healthcare industry; global economic conditions; and those other factors discussed in the section entitled "Risk Factors" in ZOLL's Annual Report on Form 10-K, which was filed with the SEC on December 15, 2006.
©2006 ZOLL Medical Corporation. All rights reserved. 269 Mill Road, Chelmsford, MA 01824-4105. Code-Ready, CPR Index, OneStep, R Series, Real CPR Help, and See-Thru CPR are trademarks of ZOLL Medical Corporation. CodeNet and ZOLL are registered trademarks of ZOLL Medical Corporation. All product names are the property of their respective owners.
Source: ZOLL Medical
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
